RBM Technology Impact on Clinical Roles: Centralized Monitoring is streamlining activities and changing roles across clinical development

Oct 18, 2017

Register Free: http://www.appliedclinicaltrialsonline.com/act_w/roles

Clinical research and development is using risk-based monitoring (RBM) to improve patient safety and study quality, while reducing costs for trials in all therapeutic areas and in all phases.  

Centralized Monitoring is automating clinical development business processes, streamlining data flow to provide earlier insights into potential safety & performance issues, and driving actions for faster resolution.  This is impacting current clinical development roles.

This webinar will highlight the technology enhancements driving streamlined clinical operations processes and functions, and will describe the benefits enabled by these enhancements. It will also highlight the shifts in role responsibilities across clinical development.



Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS

Dr. Jonas Renstroem, Associate Director, RBM and Analytics, QuintilesIMS


Date and Time:

Live: Wednesday, Oct., 18, 2017 | 11 am EDT

After the final airing of the webcast Oct. 18, 2017 it will be available on demand until Oct. 18, 2018.

Sponsor: QuintilesIMS

Register Free: http://www.appliedclinicaltrialsonline.com/act_w/roles

lorem ipsum